The extra-ordinary development in cancer vaccines- Lennard Lee & Kate Bingham

🧬 From COVID-19 Vaccines to Cancer Vaccines: Could We Transform Cancer Treatment? What if the scientific breakthroughs that helped us overcome the COVID-19 pandemic could now help us fight cancer? Dr Lennard Lee, Associate Professor at the University of Oxford and a national leader in cancer vaccine research, joins Dame Kate Bingham, former Chair of the UK Vaccine Taskforce, to explore the extraordinary potential of cancer vaccines. During the pandemic, Dame Kate Bingham led Britain’s efforts to secure COVID-19 vaccines, helping accelerate vaccine development and deployment at an unprecedented scale. Today, Dr Lennard Lee is leading pioneering research combining artificial intelligence, supercomputing and robotic laboratories to develop personalised cancer vaccines designed around each patient’s individual tumour. 🔬 The next great vaccine revolution could be in cancer. Together, their work highlights Britain’s opportunity to lead a new generation of medical breakthroughs, bringing together scientific discovery, government leadership and cutting-edge technology. 🙂 The ambition is to make personalised cancer vaccines faster to develop, more affordable and accessible to patients across the NHS and around the world. Could the lessons of the COVID-19 pandemic help us transform cancer treatment? #LennardLee #KateBingham #CancerVaccines #CancerResearch #OxfordUniversity #ArtificialIntelligence #mRNA #Immunotherapy #PersonalisedMedicine #NHS #CancerTreatment #UKScience